Lutetium PSMA Therapy

Consult With Us Consult With Us

What is Lutetium PSMA Therapy?

Advanced prostate cancer is treated with lutetium PSMA therapy, sometimes referred to as lutetium-177 prostate-specific membrane antigen therapy or lutetium-177 PSMA therapy. The protein known as PSMA, or prostate-specific membrane antigen, is present on the outer surface of prostate cancer cells.

Lutetium In PSMA therapy, a chemical that precisely targets and binds to the PSMA protein on prostate cancer cells is used in conjunction with the radioactive isotope lutetium-177. This minimises radiation harm to neighbouring healthy tissues while allowing precision radiation delivery to the cancer cells

Treatments

During the Lutetium PSMA Therapy procedure, a small amount of Lutetium-177 is injected into your bloodstream. The radioactive molecules specifically seek out and attach themselves to PSMA receptors on cancer cells, delivering a high dose of radiation directly to the tumor sites. This targeted approach allows for effective destruction of cancer cells while minimizing side effects.

Our experienced and compassionate medical staff will closely monitor your progress throughout the treatment process. We prioritize your comfort and safety, providing a supportive environment to help you feel at ease during your therapy sessions. Our team is always available to address any questions or concerns you may have, ensuring that you are well-informed and empowered throughout your treatment journey.

At Nuclear care

As leaders in the field of nuclear medicine, we remain at the forefront of advancements in Lutetium PSMA Therapy. Our commitment to continuous research and development ensures that we provide our patients with the latest innovations and best-in-class care. If you or your loved one is seeking an advanced and effective treatment option for prostate cancer, Nuclear Care MD is here to support you. Contact us today to schedule a consultation and learn more about how Lutetium PSMA Therapy can make a difference in your cancer treatment journey.

PSMA Therapy Success Stories: Nuclear Care

The success of PSMA therapy in treating prostate cancer has been demonstrated in numerous case studies and clinical trials. One such example is the case of a 73-year-old man with metastatic prostate cancer who had exhausted all other treatment options. After undergoing PSMA therapy, the patient experienced a significant reduction in his prostate-specific antigen (PSA) levels, a marker of prostate cancer activity, and a noticeable improvement in his overall health and well-being.

Another success story involves a 68-year-old man with advanced prostate cancer that had spread to his bones. Despite previous treatments, the cancer continued to progress, and the patient was experiencing debilitating pain and discomfort. However, after receiving PSMA therapy, the patient’s pain was significantly reduced, and subsequent imaging scans showed a marked decrease in the size and activity of the metastatic lesions.

These are just a few examples of the positive outcomes observed with PSMA therapy. As more patients undergo this treatment, the growing body of evidence continues to demonstrate the potential of this innovative approach to prostate cancer management.